Skip to main content
. 2017 Feb 21;3:80–84. doi: 10.1016/j.pvr.2017.02.003

Table 3.

Number of 9v HPV vaccine types detected, overall and by HIV status and age (n=606).

No of 9v vaccine HPV types Prevalence Prevalence by HIV status
Prevalence by age
% (n) Negative
n=386
% (n)
Positive
n=220
% (n)
P value 35–44
n=195
% (n)
45–54
n=229
% (n)
55–64
n=123
% (n)
65+
n=59
% (n)
P value
 (trend)
0 35.3 (214) 32.6 (126) 27.7 (61) <0.001 32.8 (64) 34.1 (78) 34.1 (42) 50.8 (30) 0.003
1 46.4 (182) 32.4 (125) 25.9 (57) 28.7 (56) 31.4 (72) 32.5 (40) 23.7 (14)
2 32.9 (129) 18.4 (71) 26.4 (58) 20.5 (40) 21.0 (48) 24.4 (30) 18.6 (11)
3 14.0 (55) 7.0 (27) 12.7 (28) 10.8 (21) 9.2 (21) 8.1 (10) 5.1 (3)
4 4.3 (17) 1.6 (6) 5.0 (11) 3.6 (7) 3.5 (8) 0.81 (1) 1.7 (1)
5 2.0 (8) 0.78 (3) 2.3 (5) 3.1 (6) 0.87 (2) 0 0
6 0.26 (1) 0.26 (1) 0 0.51 (1) 0 0 0
7 0 0 0 0 0 0 0
8 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0
Mean typesa 1.69 2.05 <0.001b 2.00 1.81 1.65 1.69 0.059b
a

Among those men with at least one HPV type detected.

b

A t-test was used to obtain p values.